| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
49,276 |
46,180 |
$5.90M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
36,088 |
32,851 |
$4.59M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
24,066 |
21,073 |
$3.24M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
6,989 |
5,719 |
$1.57M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
5,059 |
4,299 |
$1.30M |
| 70450 |
Computed tomography, head or brain; without contrast material |
4,668 |
4,000 |
$1.07M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
13,709 |
3,966 |
$733K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
6,335 |
6,062 |
$641K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
3,950 |
2,812 |
$445K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
1,754 |
1,055 |
$395K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,544 |
1,281 |
$391K |
| 80053 |
Comprehensive metabolic panel |
53,432 |
46,973 |
$372K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
7,389 |
2,227 |
$355K |
| G0378 |
Hospital observation service, per hour |
4,859 |
2,058 |
$314K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
1,768 |
1,501 |
$233K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,129 |
1,105 |
$216K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
2,838 |
1,778 |
$176K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
414 |
320 |
$167K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
1,431 |
648 |
$158K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
374 |
304 |
$150K |
| 95813 |
|
222 |
212 |
$148K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
7,977 |
2,309 |
$138K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
622 |
540 |
$133K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,211 |
683 |
$126K |
| 70496 |
|
606 |
500 |
$119K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
961 |
773 |
$117K |
| 29581 |
|
1,522 |
555 |
$114K |
| 97597 |
|
1,924 |
931 |
$106K |
| 71250 |
|
1,170 |
1,073 |
$101K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,060 |
935 |
$100K |
| 76642 |
|
741 |
669 |
$91K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
6,448 |
5,611 |
$90K |
| 71046 |
Radiologic examination, chest; 2 views |
9,044 |
8,258 |
$84K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
513 |
435 |
$84K |
| 71271 |
|
545 |
508 |
$80K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
5,500 |
4,701 |
$72K |
| 97161 |
|
1,781 |
1,501 |
$59K |
| 84484 |
|
19,153 |
13,281 |
$58K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
58,811 |
49,909 |
$56K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,927 |
798 |
$56K |
| 97016 |
|
1,857 |
511 |
$55K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
100 |
81 |
$53K |
| G0382 |
Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
605 |
600 |
$52K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,100 |
1,017 |
$52K |
| 70491 |
|
165 |
137 |
$49K |
| 12001 |
|
319 |
294 |
$49K |
| 93017 |
|
514 |
433 |
$42K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
262 |
241 |
$37K |
| H2020 |
Therapeutic behavioral services, per diem |
273 |
61 |
$37K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
22,970 |
19,510 |
$35K |
| 74018 |
|
810 |
712 |
$33K |
| 71045 |
Radiologic examination, chest; single view |
11,621 |
10,238 |
$31K |
| 72100 |
|
739 |
675 |
$29K |
| 76536 |
|
255 |
222 |
$26K |
| 36415 |
Collection of venous blood by venipuncture |
38,175 |
29,636 |
$25K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
156 |
142 |
$24K |
| 80061 |
Lipid panel |
1,401 |
1,276 |
$24K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
4,460 |
3,200 |
$23K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,810 |
1,592 |
$22K |
| 77065 |
Tomosynthesis, mammo |
528 |
431 |
$18K |
| 77066 |
Tomosynthesis, mammo |
540 |
493 |
$18K |
| 93798 |
|
330 |
39 |
$17K |
| 73630 |
|
1,334 |
1,196 |
$15K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,098 |
944 |
$15K |
| 94618 |
|
189 |
172 |
$15K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
750 |
680 |
$14K |
| 73030 |
|
972 |
854 |
$14K |
| 70486 |
|
266 |
222 |
$13K |
| 87522 |
Neg quan hep c or qual rna |
292 |
233 |
$13K |
| 86900 |
|
882 |
612 |
$13K |
| 85610 |
|
4,028 |
3,202 |
$13K |
| 80069 |
|
735 |
556 |
$13K |
| 80320 |
|
813 |
733 |
$12K |
| 73610 |
|
1,200 |
1,070 |
$12K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
1,065 |
986 |
$12K |
| 73560 |
|
605 |
542 |
$12K |
| 94060 |
|
418 |
373 |
$12K |
| 94726 |
|
547 |
498 |
$12K |
| 93975 |
|
157 |
128 |
$12K |
| 93971 |
|
146 |
127 |
$12K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,367 |
1,219 |
$12K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
6,910 |
5,029 |
$12K |
| 83605 |
|
6,201 |
4,349 |
$11K |
| 90715 |
|
806 |
654 |
$11K |
| 73130 |
|
1,063 |
925 |
$11K |
| 73562 |
|
679 |
607 |
$11K |
| 76830 |
Ultrasound, transvaginal |
416 |
344 |
$10K |
| 64721 |
|
13 |
13 |
$10K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
19,029 |
16,599 |
$10K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
12,507 |
10,406 |
$10K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
757 |
739 |
$10K |
| 72131 |
|
176 |
148 |
$10K |
| 83690 |
|
11,881 |
10,263 |
$10K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
959 |
839 |
$10K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
14 |
13 |
$10K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
208 |
39 |
$9K |
| 86140 |
|
1,001 |
708 |
$9K |
| 84703 |
|
15,951 |
14,041 |
$9K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
42 |
39 |
$9K |
| 76770 |
|
69 |
63 |
$9K |
| 97116 |
|
299 |
142 |
$8K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
4,190 |
3,748 |
$8K |
| 84439 |
|
519 |
467 |
$8K |
| 73502 |
|
444 |
384 |
$8K |
| 80076 |
|
1,025 |
795 |
$8K |
| 81001 |
|
17,887 |
15,898 |
$7K |
| 12002 |
|
43 |
38 |
$7K |
| 82607 |
|
492 |
441 |
$7K |
| 83880 |
|
3,226 |
2,749 |
$7K |
| 94729 |
|
582 |
527 |
$7K |
| 73110 |
|
800 |
699 |
$7K |
| 12011 |
|
40 |
38 |
$7K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
3,605 |
3,175 |
$6K |
| 82077 |
|
3,430 |
2,702 |
$6K |
| 72040 |
|
148 |
133 |
$6K |
| 74174 |
|
30 |
25 |
$6K |
| 82565 |
|
801 |
662 |
$6K |
| 70498 |
|
587 |
490 |
$6K |
| 83735 |
|
4,790 |
3,580 |
$6K |
| 87506 |
|
78 |
64 |
$6K |
| 96368 |
|
203 |
161 |
$6K |
| 10060 |
|
35 |
29 |
$6K |
| 85027 |
|
1,456 |
1,173 |
$6K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
873 |
731 |
$6K |
| 96367 |
|
728 |
472 |
$5K |
| 83550 |
|
500 |
456 |
$5K |
| 86850 |
|
718 |
481 |
$5K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
29 |
29 |
$5K |
| 80074 |
|
248 |
206 |
$5K |
| 82728 |
|
373 |
318 |
$5K |
| 36430 |
|
55 |
37 |
$5K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
11,682 |
5,494 |
$5K |
| 86701 |
|
131 |
112 |
$4K |
| 76870 |
|
56 |
42 |
$4K |
| 97162 |
|
226 |
185 |
$4K |
| 83970 |
|
139 |
124 |
$4K |
| 73140 |
|
322 |
284 |
$4K |
| 81003 |
|
8,965 |
7,976 |
$4K |
| 83540 |
|
518 |
470 |
$4K |
| 73080 |
|
385 |
344 |
$4K |
| 82570 |
|
426 |
356 |
$3K |
| 85652 |
|
874 |
679 |
$3K |
| 73590 |
|
369 |
331 |
$3K |
| 80329 |
|
446 |
234 |
$3K |
| 84702 |
|
609 |
464 |
$3K |
| 96376 |
|
1,981 |
1,218 |
$3K |
| 87040 |
|
2,308 |
1,039 |
$3K |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
310 |
284 |
$3K |
| 83516 |
|
109 |
84 |
$3K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
858 |
718 |
$3K |
| 97535 |
Self-care/home management training, each 15 minutes |
106 |
74 |
$3K |
| 17250 |
|
129 |
66 |
$3K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
901 |
697 |
$3K |
| 71101 |
|
169 |
148 |
$3K |
| 87390 |
|
126 |
110 |
$2K |
| 87081 |
|
3,344 |
2,994 |
$2K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
14 |
13 |
$2K |
| 86702 |
|
128 |
111 |
$2K |
| 80143 |
|
1,913 |
1,604 |
$2K |
| 85379 |
|
1,855 |
1,616 |
$2K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
44 |
42 |
$2K |
| 97166 |
|
55 |
50 |
$2K |
| 82746 |
|
384 |
342 |
$2K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
2,379 |
1,344 |
$2K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
12 |
12 |
$2K |
| 00731 |
|
295 |
232 |
$2K |
| 72141 |
|
12 |
12 |
$2K |
| 76801 |
|
17 |
13 |
$2K |
| 87324 |
|
140 |
116 |
$1K |
| 86706 |
|
59 |
43 |
$1K |
| 85730 |
|
709 |
567 |
$1K |
| 82803 |
|
2,515 |
1,968 |
$1K |
| 82784 |
|
70 |
55 |
$1K |
| 86901 |
|
881 |
612 |
$1K |
| 93970 |
|
13 |
12 |
$1K |
| 80179 |
|
1,862 |
1,570 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,254 |
3,852 |
$1K |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
56 |
38 |
$1K |
| 84156 |
|
232 |
203 |
$1K |
| 97165 |
|
13 |
13 |
$1K |
| 87186 |
|
1,059 |
844 |
$990.17 |
| 87077 |
|
1,204 |
906 |
$943.16 |
| 87449 |
|
193 |
151 |
$898.89 |
| 82550 |
|
567 |
414 |
$892.28 |
| 87210 |
|
603 |
499 |
$883.03 |
| 72070 |
|
20 |
15 |
$880.57 |
| 87340 |
|
47 |
30 |
$862.70 |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
14 |
13 |
$855.74 |
| 73090 |
|
208 |
182 |
$799.95 |
| 87070 |
|
558 |
388 |
$782.61 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
1,695 |
746 |
$747.43 |
| 97014 |
|
22 |
12 |
$721.41 |
| 84520 |
|
94 |
65 |
$658.07 |
| 82105 |
|
70 |
58 |
$608.71 |
| 84145 |
|
816 |
658 |
$589.09 |
| 86480 |
|
13 |
12 |
$583.91 |
| 83013 |
|
14 |
12 |
$562.51 |
| 86038 |
|
35 |
30 |
$541.75 |
| 87336 |
|
57 |
48 |
$530.45 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
11,212 |
9,467 |
$522.14 |
| 87328 |
|
57 |
48 |
$472.79 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,505 |
934 |
$459.78 |
| 84550 |
|
103 |
80 |
$433.56 |
| 87205 |
|
559 |
346 |
$433.06 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,542 |
960 |
$407.38 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
10,184 |
8,803 |
$387.41 |
| 87807 |
|
369 |
310 |
$271.19 |
| J1953 |
Injection, levetiracetam, 10 mg |
24 |
15 |
$269.13 |
| 82785 |
|
19 |
15 |
$264.19 |
| 82103 |
|
14 |
12 |
$254.97 |
| 87088 |
|
191 |
163 |
$216.05 |
| 82653 |
|
17 |
12 |
$206.18 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
124 |
117 |
$204.24 |
| 86803 |
|
15 |
12 |
$198.06 |
| 82140 |
|
108 |
84 |
$196.20 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
10,220 |
8,108 |
$192.60 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
2,499 |
2,101 |
$182.71 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
506 |
386 |
$164.44 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,578 |
1,200 |
$145.63 |
| 00910 |
|
60 |
50 |
$128.72 |
| J2704 |
Injection, propofol, 10 mg |
4,840 |
2,876 |
$126.00 |
| 82043 |
|
18 |
13 |
$111.95 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
643 |
362 |
$107.90 |
| 84100 |
|
67 |
42 |
$104.83 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
243 |
199 |
$104.10 |
| 85048 |
|
13 |
12 |
$99.77 |
| 83993 |
|
19 |
12 |
$99.51 |
| 85018 |
|
97 |
50 |
$95.71 |
| J1644 |
Injection, heparin sodium, per 1000 units |
700 |
389 |
$93.89 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
17 |
15 |
$84.40 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,241 |
1,728 |
$82.86 |
| 85014 |
|
65 |
38 |
$79.29 |
| J2785 |
Injection, regadenoson, 0.1 mg |
256 |
210 |
$73.51 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,176 |
802 |
$72.37 |
| 88304 |
|
439 |
349 |
$70.02 |
| 82270 |
|
156 |
133 |
$68.14 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
720 |
550 |
$67.73 |
| J2060 |
Injection, lorazepam, 2 mg |
743 |
561 |
$63.01 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
2,585 |
2,029 |
$62.09 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
643 |
465 |
$55.25 |
| J1790 |
Injection, droperidol, up to 5 mg |
420 |
343 |
$54.69 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
277 |
179 |
$53.36 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
47 |
26 |
$51.64 |
| J3490 |
Unclassified drugs |
46 |
15 |
$47.65 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
974 |
670 |
$44.83 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
846 |
636 |
$39.50 |
| 84450 |
|
15 |
13 |
$39.03 |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
415 |
312 |
$35.10 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
543 |
457 |
$31.68 |
| J7050 |
Infusion, normal saline solution, 250 cc |
275 |
203 |
$30.82 |
| J0692 |
Injection, cefepime hydrochloride, 500 mg |
169 |
73 |
$30.18 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
95 |
62 |
$26.75 |
| 84460 |
|
13 |
13 |
$26.00 |
| 84132 |
|
121 |
101 |
$25.85 |
| 94761 |
|
735 |
295 |
$20.52 |
| Q9963 |
High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml |
562 |
494 |
$18.82 |
| C1769 |
Guide wire |
59 |
45 |
$16.94 |
| J3480 |
Injection, potassium chloride, per 2 meq |
210 |
111 |
$14.62 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
90 |
66 |
$13.75 |
| J0688 |
Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg |
328 |
274 |
$11.70 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
461 |
322 |
$11.66 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
31 |
26 |
$9.50 |
| 82010 |
|
95 |
80 |
$8.01 |
| J1630 |
Injection, haloperidol, up to 5 mg |
33 |
26 |
$6.75 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,491 |
1,112 |
$5.63 |
| J1940 |
Injection, furosemide, up to 20 mg |
37 |
25 |
$3.68 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
28 |
24 |
$1.97 |
| J0456 |
Injection, azithromycin, 500 mg |
38 |
25 |
$1.79 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
382 |
354 |
$0.12 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
34 |
26 |
$0.00 |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
637 |
551 |
$0.00 |
| A4648 |
Tissue marker, implantable, any type, each |
42 |
26 |
$0.00 |
| 88342 |
|
156 |
111 |
$0.00 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
15 |
13 |
$0.00 |
| 94760 |
|
75 |
67 |
$0.00 |
| C1819 |
Surgical tissue localization and excision device (implantable) |
39 |
24 |
$0.00 |
| 00790 |
|
15 |
13 |
$0.00 |
| C9399 |
Unclassified drugs or biologicals |
16 |
14 |
$0.00 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
14 |
13 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
35 |
33 |
$0.00 |
| 82150 |
|
19 |
15 |
$0.00 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
14 |
13 |
$0.00 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
13 |
13 |
$0.00 |
| 29125 |
|
136 |
121 |
$0.00 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
72 |
63 |
$0.00 |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
63 |
35 |
$0.00 |
| 01810 |
|
46 |
43 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
12 |
12 |
$0.00 |
| 00811 |
|
13 |
12 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
12 |
12 |
$0.00 |
| 00812 |
|
15 |
12 |
$0.00 |